Cellective BioTherapy is among the first-time presenting companies selected for the 2018 CED Life Science Conference to be held Feb. 27-28, 2018.
Welcome to our new website; we invite you to look around. Please contact us if you have questions about our B cell immunotherapies. You may also sign up to be automatically notified by email any time we post news to our site.
Recent article from The Triangle Business Journal detailing the recent Eshelman investment in Cellective BioTherapy.